BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1024 related articles for article (PubMed ID: 26742101)

  • 21. The Tail That Wags the Dog: How the Disordered C-Terminal Domain Controls the Transcriptional Activities of the p53 Tumor-Suppressor Protein.
    Laptenko O; Tong DR; Manfredi J; Prives C
    Trends Biochem Sci; 2016 Dec; 41(12):1022-1034. PubMed ID: 27669647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of Intrinsic Protein Disorder in the Function and Interactions of the Transcriptional Coactivators CREB-binding Protein (CBP) and p300.
    Dyson HJ; Wright PE
    J Biol Chem; 2016 Mar; 291(13):6714-22. PubMed ID: 26851278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of the K24N mutation on the transactivation domain of p53 and its binding to murine double-minute clone 2.
    Zhan YA; Wu H; Powell AT; Daughdrill GW; Ytreberg FM
    Proteins; 2013 Oct; 81(10):1738-47. PubMed ID: 23609977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer-Associated Mutations Perturb the Disordered Ensemble and Interactions of the Intrinsically Disordered p53 Transactivation Domain.
    Schrag LG; Liu X; Thevarajan I; Prakash O; Zolkiewski M; Chen J
    J Mol Biol; 2021 Jul; 433(15):167048. PubMed ID: 33984364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probing the dynamics of disorder.
    Fox SJ; Kannan S
    Prog Biophys Mol Biol; 2017 Sep; 128():57-62. PubMed ID: 28554553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alanine and proline content modulate global sensitivity to discrete perturbations in disordered proteins.
    Perez RB; Tischer A; Auton M; Whitten ST
    Proteins; 2014 Dec; 82(12):3373-84. PubMed ID: 25244701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contribution of proline to the pre-structuring tendency of transient helical secondary structure elements in intrinsically disordered proteins.
    Lee C; Kalmar L; Xue B; Tompa P; Daughdrill GW; Uversky VN; Han KH
    Biochim Biophys Acta; 2014 Mar; 1840(3):993-1003. PubMed ID: 24211251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solution structure of the TAZ2 (CH3) domain of the transcriptional adaptor protein CBP.
    De Guzman RN; Liu HY; Martinez-Yamout M; Dyson HJ; Wright PE
    J Mol Biol; 2000 Oct; 303(2):243-53. PubMed ID: 11023789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic folding of two intrinsically disordered proteins: searching for conformational selection.
    Ganguly D; Zhang W; Chen J
    Mol Biosyst; 2012 Jan; 8(1):198-209. PubMed ID: 21766125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electronic Polarization at the Interface between the p53 Transactivation Domain and Two Binding Partners.
    Corrigan AN; Lemkul JA
    J Phys Chem B; 2022 Jul; 126(26):4814-4827. PubMed ID: 35749260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphorylation of an intrinsically disordered segment in Ets1 shifts conformational sampling toward binding-competent substates.
    Bui JM; Gsponer J
    Structure; 2014 Aug; 22(8):1196-1203. PubMed ID: 25017730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Folding and structural polymorphism of p53 C-terminal domain: One peptide with many conformations.
    Kumar A; Kumar P; Kumari S; Uversky VN; Giri R
    Arch Biochem Biophys; 2020 May; 684():108342. PubMed ID: 32184088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NMR chemical shift and relaxation measurements provide evidence for the coupled folding and binding of the p53 transactivation domain.
    Vise PD; Baral B; Latos AJ; Daughdrill GW
    Nucleic Acids Res; 2005; 33(7):2061-77. PubMed ID: 15824059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extended string binding mode of the phosphorylated transactivation domain of tumor suppressor p53.
    Okuda M; Nishimura Y
    J Am Chem Soc; 2014 Oct; 136(40):14143-52. PubMed ID: 25216154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Temperature effects on the hydrodynamic radius of the intrinsically disordered N-terminal region of the p53 protein.
    Langridge TD; Tarver MJ; Whitten ST
    Proteins; 2014 Apr; 82(4):668-78. PubMed ID: 24150971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-range modulation of chain motions within the intrinsically disordered transactivation domain of tumor suppressor p53.
    Lum JK; Neuweiler H; Fersht AR
    J Am Chem Soc; 2012 Jan; 134(3):1617-22. PubMed ID: 22176582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phosphorylation-dependent switch in the disordered p53 transactivation domain regulates DNA binding.
    Sun X; Dyson HJ; Wright PE
    Proc Natl Acad Sci U S A; 2021 Jan; 118(1):. PubMed ID: 33443163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2.
    Ferreon JC; Lee CW; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
    Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6591-6. PubMed ID: 19357310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p53 Phosphomimetics Preserve Transient Secondary Structure but Reduce Binding to Mdm2 and MdmX.
    Levy R; Gregory E; Borcherds W; Daughdrill G
    Biomolecules; 2019 Mar; 9(3):. PubMed ID: 30832340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding Kinetics of the Intrinsically Disordered p53 Family Transactivation Domains and MDM2.
    Åberg E; Karlsson OA; Andersson E; Jemth P
    J Phys Chem B; 2018 Jul; 122(27):6899-6905. PubMed ID: 29878773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.